Theragen Etex Co.Ltd (066700) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.020x

Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has a cash flow conversion efficiency ratio of 0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.08 Billion ≈ $2.09 Million USD) by net assets (₩152.04 Billion ≈ $103.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Theragen Etex Co.Ltd for the company's overall valuation and market capitalisation.

Theragen Etex Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Theragen Etex Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Theragen Etex Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theragen Etex Co.Ltd ranked by their cash flow conversion efficiency. Explore 066700 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Xander International TWO:6118	-0.158x
S P V I Public Company Limited BK:SPVI	0.102x
RMB Holdings Ltd JSE:RMH	-0.038x
Better World Green Public Company Limited BK:BWG	0.032x
Circle8 Group, Inc. NASDAQ:CIRC	-0.181x
Amicogen Inc KQ:092040	-0.027x
RFTech Co. Ltd KQ:061040	-0.045x
Krynica Vitamin SA WAR:KVT	0.004x

Annual Cash Flow Conversion Efficiency for Theragen Etex Co.Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2025. View Theragen Etex Co.Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.17 Billion ≈ $107.87 Million	₩10.97 Billion ≈ $7.44 Million	0.069x	+403.28%
2024-12-31	₩130.54 Billion ≈ $88.47 Million	₩1.79 Billion ≈ $1.21 Million	0.014x	-82.72%
2023-12-31	₩152.93 Billion ≈ $103.64 Million	₩12.12 Billion ≈ $8.22 Million	0.079x	+18.67%
2022-12-31	₩143.60 Billion ≈ $97.31 Million	₩9.59 Billion ≈ $6.50 Million	0.067x	+271.32%
2021-12-31	₩222.70 Billion ≈ $150.92 Million	₩4.01 Billion ≈ $2.72 Million	0.018x	-49.11%
2020-12-31	₩374.12 Billion ≈ $253.54 Million	₩13.23 Billion ≈ $8.96 Million	0.035x	+12645.45%
2019-12-31	₩135.86 Billion ≈ $92.07 Million	₩37.69 Million ≈ $25.54K	0.000x	+100.12%
2018-12-31	₩80.92 Billion ≈ $54.84 Million	₩-18.58 Billion ≈ $-12.59 Million	-0.230x	-1223.09%
2017-12-31	₩86.93 Billion ≈ $58.91 Million	₩1.78 Billion ≈ $1.20 Million	0.020x	+117.59%
2016-12-31	₩72.10 Billion ≈ $48.86 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.116x	-1825.75%
2015-12-31	₩68.82 Billion ≈ $46.64 Million	₩-415.37 Million ≈ $-281.49K	-0.006x	-1338.61%
2014-12-31	₩82.00 Billion ≈ $55.57 Million	₩39.95 Million ≈ $27.08K	0.000x	-99.59%
2008-12-31	₩26.20 Billion ≈ $17.76 Million	₩3.14 Billion ≈ $2.13 Million	0.120x	--

About Theragen Etex Co.Ltd

KQ:066700 Korea Pharmaceuticals

Market Cap

$43.37 Million

₩64.00 Billion KRW

Market Cap Rank

#22508 Global

#1444 in Korea

Share Price

₩2100.00

Change (1 day)

-0.71%

52-Week Range

₩1888.00 - ₩3315.00

All Time High

₩21800.00